甘李药业股份有限公司关于公司持股5%以上股东部分股份解押的公告

Group 1 - The core point of the announcement is that Beijing Xutong Hongda Technology Co., Ltd. has completed the release of 600,000 shares of Ganli Pharmaceutical, reducing its pledged shares to 23,410,000, which is 72.99% of its holdings [1][2] - After the release of the pledge, the total shares held by the controlling shareholder and actual controller, Mr. Gan Zhongru, and Xutong Hongda is 237,717,491 shares, accounting for 39.80% of the total share capital [1][2] - The company states that the financial condition of the 5% shareholder, Xutong Hongda, is good, and there are no risks of forced liquidation or transfer of pledged shares, indicating that the pledge risk is under control and will not materially affect the company's operations [2] Group 2 - As of the announcement date, the cumulative pledged shares of the aforementioned shareholders and their concerted actions are detailed, showing the extent of share pledges [2] - The company will continue to monitor the stock pledge situation and risks of the 5% shareholder, Xutong Hongda, and will disclose relevant information in a timely manner according to regulations [2]